The fusion landscape of hepatocellular carcinoma
Open Access
- 23 March 2019
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 13 (5) , 1214-1225
Abstract
Most cases of hepatocellular carcinoma (HCC) are already advanced at the time of diagnosis, which limits treatment options. Challenges in early‐stage diagnosis may be due to the genetic complexity of HCC. Gene fusion plays a critical function in tumorigenesis and cancer progression in multiple cancers, yet the identities of fusion genes as potential diagnostic markers in HCC have not been investigated. Here, we employed STAR‐Fusion and identified 43 recurrent fusion events in our own and four public RNA‐seq datasets. We identified 2354 different gene fusions in two hepatitis B virus (HBV)‐HCC patients. Validation analysis against the four RNA‐seq datasets revealed that only 1.8% (43/2354) were recurrent fusions. Comparison with the four fusion databases demonstrated that 19 recurrent fusions were not previously annotated to diseases and three were annotated as disease‐related fusion events. Finally, we validated six of the novel fusion events, including RP11‐476K15.1‐CTD‐2015H3.2, by RT‐PCR and Sanger sequencing of 14 pairs of HBV‐related HCC samples. In summary, our study provides new insights into gene fusions in HCC and may contribute to the development of anti‐HCC therapy.Keywords
Funding Information
- Chinese Academy of Medical Sciences (2017‐I2M‐4‐003)
- Natural Science Foundation of Beijing Municipality (L172055)
This publication has 48 references indexed in Scilit:
- ViralFusionSeq: accurately discover viral integration events and reconstruct fusion transcripts at single-base resolutionBioinformatics, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- TopHat-Fusion: an algorithm for discovery of novel fusion transcriptsGenome Biology, 2011
- Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical TrialsJournal of Clinical Oncology, 2010
- Recurrence Patterns After Hepatectomy of Hepatocellular Carcinoma: Implication of Milan Criteria UtilizationAnnals of Surgical Oncology, 2009
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- The impact of translocations and gene fusions on cancer causationNature Reviews Cancer, 2007
- Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemiaOncogene, 2004
- Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learningNature Medicine, 2003